Company Directory / research
PrivateFor profitresearchCambridge, United States
Ring Therapeutics
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
- Founded
- 2017 9 years ago
- Staff
- 101-250 band, as listed
- Followers
- - on LinkedIn
- Funding
- $254M as listed, currency not stated
Set against six million companies
Size
101-250 people: larger than 85% of companies with a size listed
Age
9 years old.
Reach
Website ranked #5,219,993 in the world for traffic, about 1k visits a month.
What it does
BiotechnologyHealth CareTherapeutics
Funding, as listed
$254M currency not stated
- Rounds3
- LatestSeries c, Mar 2023
- Investors9, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Ring Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Ring Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2017
- Founders
- Avak Kahvejian, Erica Weinstein, Noubar Afeyan
- Industry
- research
- Categories
- Biotechnology, Health Care, Therapeutics
Where
- City
- Cambridge
- Country
- United States
- Markets
- Greater Boston Area, East Coast, New England, Northeastern US
Size and reach
- Staff band
- 101-250
- Web traffic rank
- #5,219,993
- Monthly web visits
- 1,494
Funding, as listed
- Total
- 253,500,000 (currency not stated)
- Rounds
- 3
- Latest round
- Series c
- Latest round date
- Mar 2023
- Investors
- 9
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Ring Therapeutics may be growing as evidenced by their development of a new class of viral vector that is re-dosable in primates, which addresses a significant challenge associated with adeno-associated viruses. Furthermore, the company has made a major step toward clinical trials as their human viral vector has successfully delivered gene therapy to the eyes of mice. These advancements suggest progress in their research and development capabilities. Additionally, there is no mention of layoffs or staff reductions at Ring Therapeutics, which contrasts with the broader trend of layoffs in the biopharma industry, indicating stability within the company.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.